US2007135400A1PendingUtilityA1

Estradiol derivatives

49
Assignee: AGOSTON GREGORY EPriority: May 28, 2003Filed: Feb 2, 2007Published: Jun 14, 2007
Est. expiryMay 28, 2023(expired)· nominal 20-yr term from priority
Inventors:Gregory AgostonTheresa LavalleeVictor PribludaJamshed H. ShahAnthony Treston
A61P 9/10A61P 9/00A61P 37/06A61P 7/06A61P 7/02A61P 37/02A61P 37/08A61P 31/04A61P 35/00A61P 31/10A61P 35/02A61P 31/22A61P 27/06A61P 27/02A61P 25/00A61P 31/18A61P 29/00A61P 31/00A61P 1/04A61P 13/08A61P 13/02A61P 15/00A61P 13/12A61P 1/16A61P 17/00A61P 19/02C07J 41/00A61P 1/00A61P 17/06A61P 21/00A61P 11/00
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Compositions and methods for treating mammalian disease characterized by undesirable angiogenesis by administering compounds of the general formula: wherein the variables are defined in the specification.

Claims

exact text as granted — not AI-modified
1 - 197 . (canceled)  
   
   
       198 . A compound selected from  
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
     
   
   
       199 . The compound of claim  1 , wherein the compound is:  
     
       
         
         
             
             
         
       
     
   
   
       200 . The compound of claim  1 , wherein the compound is:  
     
       
         
         
             
             
         
       
     
   
   
       201 . The compound of claim  1 , wherein the compound is:  
     
       
         
         
             
             
         
       
     
   
   
       202 . The compound of claim  1 , wherein the compound is:  
     
       
         
         
             
             
         
       
     
   
   
       203 . The compound of claim  1 , wherein the compound is:  
     
       
         
         
             
             
         
       
     
   
   
       204 . The compound of claim  1 , wherein the compound is:  
     
       
         
         
             
             
         
       
     
   
   
       205 . The compound of claim  1 , wherein the compound is:  
     
       
         
         
             
             
         
       
     
   
   
       206 . The compound of claim  1 , wherein the compound is:  
     
       
         
         
             
             
         
       
     
   
   
       207 . The compound of claim  1 , wherein the compound is:  
     
       
         
         
             
             
         
       
     
   
   
       208 . The compound of claim  1 , wherein the compound is:  
     
       
         
         
             
             
         
       
     
   
   
       209 . The compound of claim  1 , wherein the compound is:  
     
       
         
         
             
             
         
       
     
   
   
       210 . The compound of claim  1 , wherein the compound is:  
     
       
         
         
             
             
         
       
     
   
   
       211 . The compound of claim  1 , wherein the compound is:

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.